Video Experimental Relacionado
Updated: Jul 27, 2026
07:09
Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
Published on: April 1, 2015
Resumen
Virchow fue uno de ellos.
Área de la Ciencia:
- Hematología Hematología.
- Biología Vascular Biología Vascular
- Investigación de la trombosis Investigación de la trombosis
Sus antecedentes:
- La comprensión de la trombosis se basa en la tríada de Virchow: daño vascular, cambios en el flujo sanguíneo e hipercoagulabilidad.
- Los estados hipercoagulables implican un aumento de los factores de coagulación, el recuento de plaquetas, los factores de coagulación activados o alteraciones cualitativas.
- Las deficiencias en anticoagulantes naturales como la antitrombina III y la proteína C están relacionadas con el tromboembolismo recurrente.
Objetivo del estudio:
- Explorar la naturaleza multifacética de la hipercoagulabilidad y su papel en la trombosis.
- Revisar la evidencia que vincula los niveles de factor de coagulación, la función plaquetaria y las deficiencias de anticoagulantes con el riesgo trombótico.
- Examinar las implicaciones de la fibrinólisis alterada en la predisposición trombótica.
Principales métodos:
- Revisión de la literatura existente y las teorías establecidas sobre la trombosis.
- Análisis de las correlaciones entre los parámetros hematológicos y la tendencia trombótica.
- Examen de la evidencia clínica de pacientes con trastornos hereditarios de la coagulación.
Principales resultados:
- El aumento de los factores de coagulación y el recuento de plaquetas puede estar correlacionado con el riesgo trombótico.
- Los niveles elevados de factores de coagulación activados y las alteraciones cualitativas de la sangre son posibles contribuyentes a la trombosis.
- Las deficiencias familiares de antitrombina III y proteína C están fuertemente asociadas con el tromboembolismo recurrente.
Conclusiones:
- Las alteraciones en la composición de la sangre, incluidos los factores de coagulación y los anticoagulantes naturales, juegan un papel importante en la trombosis.
- La fibrinólisis deteriorada también puede predisponer a las personas a eventos trombóticos.
- Se necesita más investigación para explicar por qué las personas con alteraciones hemostáticas de por vida experimentan menos episodios trombóticos.
Videos de Conceptos Relacionados
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:20Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
01:29Pulmonary Embolism I: Introduction
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
01:19Pulmonary Embolism I: Introduction
A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...